CDH1 and non-small cell lung carcinoma: Furthermore, a large body of cancer-related literature, including that on non-small-cell lung carcinoma (NSCLC), gastric, pancreatic endocrine and breast cancers, highlighted a strong correlation between poor prognosis and tumors with lost or decreased expression of epithelial markers, such as E-cadherin or catenins [38,39,40,41,42,43].